About us

On a mission to bring innovative software solutions to the biomedical field

The ENPICOM dream

We make up a top-class and diverse team of experts, with the right combination of knowledge and expertise to jointly tackle the data analysis and software engineering challenges related to the field of immunomics. Together with our scientific and strategic partners and supported by our investors, we aim to develop tools and validate applications to truly bridge the gap between immune repertoire sequencing and the insights needed to improve the health of patients treated with immunotherapy or affected by immune system related diseases or conditions.


Mission and vision

ENPICOM aims to become the global leader in personalizing immunotherapy with groundbreaking bioinformatics methods and state-of-the-art software to accelerate drug development, and improve patient stratification & treatment monitoring of immunotherapies.

Innovative repertoire sequencing data management, analysis, and visualization will empower biopharma companies and doctors to make the adaptive immune system our strongest weapon in the battle against deadly diseases.

Our culture

Combine the serious business with joy and laugther

Have fun

Going to work with a smile changes everything.

ENPICOM Team members canoeing

Strive for excellence

Excellence is not an exception, it is a prevailing attitude.

Enjoy teamwork

Talent wins games, but teamwork and intelligence win championships.

Be passionate

Passion is energy. Feel the power that comes from focusing on what excites you.

Innovate disruptively

Innovation distinguishes between a leader and a follower.

Embrace diversity

We work in an environment where inclusivity is a priority and everyone’s ideas are valued.

Our people

Wide variety of people coming together

The ENPICOM team

Nicola Bonzanni

Founder & Chief Product Officer

Jos Lunenberg

Strategic Advisor to the Board

Paul van der Velde

Chief Executive Officer

Daan Prince

Chief Financial Officer

Anke Thönissen-Maertens

Head of Operations

Lorenzo Fanchi

Product Management Team Lead

Thijs Maas

Bioinformatics Developer

Pim Fuchs

Bioinformatics Team Lead

Gergana Bounova

Machine Learning Scientist

Henk-Jan van den Ham

Research Team Lead

Michiel Gielen

Operations Development Team Lead

Jorrit Posthuma

Apps Development Team Lead

Lana Lozova

Marketing Team Lead

Néstor Vázquez Bernat

Application Science Team Lead

Piotr van Rijssel

Application Scientist

Sjors de Waard

Sales Executive

Luís Alves de Sousa Rêgo

Software Engineer

Klarinda de Zwaan

Application Support Assistant

Stefan Lelieveld

Bioinformatics Scientist

Rory Matthews

Software Engineer

Steven Liebregt

Software Engineer

Wenying Chang

UX/UI Designer

Przemysław Nowak

Senior SE Consultant

Mateusz Safaryjski

SE Consultant

Niki Efstratiou

UX designer

Robin Blonk

Sales Development Scientist

Roos Bressers

Quality Assurance Tester

Bart Versteeg

Platform Development Team Lead

Okan Aydin

Business Development Scientist

Paul Saary

Bioinformatics Developer

Scientific advisory board

  • Dr. Eline (Nina) Luning Prak is a Professor of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania. Dr. Luning Prak studies antibody repertoire in health and disease and directs the Human Immunology Core lab at Penn. In addition, Dr. Luning Prak is the current chair of the Executive Sub-committee of the AIRR Community that is establishing data standards for NGS immune repertoire profiling studies.

  • Victor Greiff is an Associate Professor for Computational and Systems Immunology at the University of Oslo. His work focuses specifically on the development of machine learning, computational and experimental tools for the analysis of adaptive immune receptor repertoires to facilitate the in silico design of immune receptor-based immunodiagnostics and immunotherapeutics.


On March 5, 2019, ENPICOM closed a Series A investment round. BOM Brabant Ventures, Nextgen Ventures, and Arches Capital jointly invested 1.2 million euros to support the company’s repertoire sequencing data analysis platform.

Press release

On January 13, 2022, ENPICOM closed a Series B investment round led by BOP Capital.

press release

Strategic partners

On May 9, 2019, ENPICOM announced a collaboration with DDL Diagnostic Laboratory, a state-of-the-art laboratory specializing in molecular diagnostic testing and assay development, to jointly deliver immune repertoire sequencing and analysis service.

press release
Academic partners